Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Bottom line

But are you liking that at 4 shares to $1, Crossflo's $7.4 million amounts to a 29.6 million share (possible redilution if sold) likely bought at a higher price avg. by mgmt?...........If you didn't think surviving Swartz was enough........

I'm at least wishing we buy the same amount now at these prices, and maybe we get a writeoff on the Crossflo shares using the first in, first out basis........heheh.......

Share
New Message
Please login to post a reply